University Multiprofile Hospital for Active Treatment- UMHAT Sveta Anna AD

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension	lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder	Active, not recruiting	Phase 3	2026-10-06	NCT04273945
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation	Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder	Active, not recruiting	Phase 3	2026-09-25	NCT05757869
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Active, not recruiting	Phase 3	2026-09-25	NCT05702034
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option	cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder	Recruiting	Phase 3	2026-09-25	NCT05179876

Clinical trials